Related references
Note: Only part of the references are listed.Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells
Shibo Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Junmin Zhang et al.
MEDICINAL RESEARCH REVIEWS (2021)
Natural Molecules Targeting Thioredoxin System and Their Therapeutic Potential
Junmin Zhang et al.
ANTIOXIDANTS & REDOX SIGNALING (2021)
Functionalized PDA/DEX-PEI@HA nanoparticles combined with sleeping-beauty transposons for multistage targeted delivery of CRISPR/Cas9 gene
Kun Ma et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Synthesis and biological evaluation of disulfides as anticancer agents with thioredoxin inhibition
Xiangxu Wei et al.
BIOORGANIC CHEMISTRY (2021)
Efficient purification of selenoprotein thioredoxin reductase 1 by using chelating reagents to protect the affinity resins and rescue the enzyme activities
Shibo Sun et al.
PROCESS BIOCHEMISTRY (2021)
Oxidative stress-mediated AMPK inactivation determines the high susceptibility of LKB1-mutant NSCLC cells to glucose starvation
Yi Ren et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition
Hongyu Ding et al.
SCIENCE ADVANCES (2021)
Chlorophyllin Inhibits Mammalian Thioredoxin Reductase 1 and Triggers Cancer Cell Death
Shibo Sun et al.
ANTIOXIDANTS (2021)
Menadione inhibits thioredoxin reductase 1 via arylation at the Sec498 residue and enhances both NADPH oxidation and superoxide production in Sec498 to Cys498 substitution
Shibo Sun et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Thioredoxin reductase as a pharmacological target
Geir Bjorklund et al.
PHARMACOLOGICAL RESEARCH (2021)
KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition
Pranavi Koppula et al.
ISCIENCE (2021)
Inhibition of thioredoxin reductase 1 correlates with platinum-based chemotherapeutic induced tissue injury
Ping Cheng et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
Laura Torrente et al.
REDOX BIOLOGY (2020)
Shikonin Attenuates Hepatic Steatosis by Enhancing Beta Oxidation and Energy Expenditure via AMPK Activation
So Young Gwon et al.
NUTRIENTS (2020)
Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer
Xiaoguang Liu et al.
NATURE CELL BIOLOGY (2020)
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
Qin Wu et al.
NATURE COMMUNICATIONS (2020)
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
Rodrigo Romero et al.
NATURE CANCER (2020)
Shikonin induces colorectal carcinoma cells apoptosis and autophagy by targeting galectin-1/JNK signaling axis
Nan Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update
Junmin Zhang et al.
MEDICINAL RESEARCH REVIEWS (2019)
Shikonin derivatives for cancer prevention and therapy
Joelle C. Boulos et al.
CANCER LETTERS (2019)
Promotion of HeLa cells apoptosis by cynaropicrin involving inhibition of thioredoxin reductase and induction of oxidative stress
Tianyu Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
The combination of ascorbate and menadione causes cancer cell death by oxidative stress and replicative stress
Xiaoyuan Ren et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
MLKL contributes to shikonin-induced glioma cell necroptosis via promotion of chromatinolysis
Ye Ding et al.
CANCER LETTERS (2019)
Pharmacological properties and derivatives of shikonin-A review in recent years
Chuanjie Guo et al.
PHARMACOLOGICAL RESEARCH (2019)
The production of reactive oxygen species enhanced with the reduction of menadione by active thioredoxin reductase
Jing Li et al.
METALLOMICS (2019)
NRF2 and the Hallmarks of Cancer
Montserrat Rojo de la Vega et al.
CANCER CELL (2018)
Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis
Xiaoyue Zhao et al.
SCIENTIFIC REPORTS (2018)
Thioredoxin reverses age-related hypertension by chronically improving vascular redox and restoring eNOS function
Rob H. P. Hilgers et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Targeting the Thioredoxin System for Cancer Therapy
Junmin Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Identification of new shikonin derivatives as STAT3 inhibitors
Han-Yue Qiu et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities
Jianqiang Xu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
The conserved Trp114 residue of thioredoxin reductase 1 has a redox sensor-like function triggering oligomerization and crosslinking upon oxidative stress related to cell death
J. Xu et al.
CELL DEATH & DISEASE (2015)
Selenium as an Electron Acceptor during the Catalytic Mechanism of Thioredoxin Reductase
Adam P. Lothrop et al.
BIOCHEMISTRY (2014)
Why Is Mammalian Thioredoxin Reductase 1 So Dependent upon the Use of Selenium?
Adam P. Lothrop et al.
BIOCHEMISTRY (2014)
The thioredoxin antioxidant system
Jun Lu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells
Dongzhu Duan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Selenium and selenocysteine: roles in cancer, health, and development
Dolph L. Hatfield et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Wobble decoding by the Escherichia coli selenocysteine insertion machinery
Jianqiang Xu et al.
NUCLEIC ACIDS RESEARCH (2013)
APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase
X. Peng et al.
CELL DEATH & DISEASE (2013)
The Chemical Biology of Naphthoquinones and Its Environmental Implications
Yoshito Kumagai et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Pyrroloquinoline quinone modulates the kinetic parameters of the mammalian selenoprotein thioredoxin reductase 1 and is an inhibitor of glutathione reductase
Jianqiang Xu et al.
BIOCHEMICAL PHARMACOLOGY (2012)
In vivo redox state of Human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)
J. Ungerstedt et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide involves activation of redox sensitive ASK1-JNK/p38MAPK signaling in head and neck cancer cells
Pradeep Kumar Sharma et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Glutathione and Glutaredoxin Act as a Backup of Human Thioredoxin Reductase 1 to Reduce Thioredoxin 1 Preventing Cell Death by Aurothioglucose
Yatao Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Crystal structure of the human thioredoxin reductase-thioredoxin complex
Karin Fritz-Wolf et al.
NATURE COMMUNICATIONS (2011)
Focus on mammalian thioredoxin reductases - Important selenoproteins with versatile functions
Elias S. J. Arner
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy
Sofl E. Eriksson et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Crystal Structure and Catalysis of the Selenoprotein Thioredoxin Reductase 1
Qing Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Molecular Mechanisms of Thioredoxin and Glutaredoxin as Hydrogen Donors for Mammalian S Phase Ribonucleotide Reductase
Farnaz Zahedi Avval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Inhibition of the human thioredoxin system - A molecular mechanism of mercury toxicity
Cristina M. L. Carvalho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Cell Death by SecTRAPs: Thioredoxin Reductase as a Prooxidant Killer of Cells
Karin Anestal et al.
PLOS ONE (2008)
The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis
Karin Fritz-Wolf et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism
EI Biterova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Interactions of quinones with thioredoxin reductase -: A challenge to the antioxidant role of the mammalian selenoprotein
N Cenas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress
DDK Smart et al.
CANCER RESEARCH (2004)
Three-dimensional structure of a mammalian thioredoxin reductase: Implications for mechanism and evolution of a selenocysteine-dependent enzyme
T Sandalova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Roles of N-terminal active cysteines and C-terminal cysteine-selenocysteine in the catalytic mechanism of mammalian thioredoxin reductase
N Fujiwara et al.
JOURNAL OF BIOCHEMISTRY (2001)
Structure and mechanism of mammalian thioredoxin reductase:: The active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence
LW Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
